4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-001265
CFO & Chief Business Officer sold 14,905 shares at an average $1.97 ($29,436)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2026-01-05 | Sale | −4,000 | $1.96 | $7,842 | 227,744 | D |
| Zuga Matt CFO & Chief Business Officer | 2026-01-06 | Sale | −5,100 | $1.97 | $10,028 | 222,644 | D |
| Zuga Matt CFO & Chief Business Officer | 2026-01-07 | Sale | −4,105 | $2.00 | $8,189 | 218,539 | D |
| Zuga Matt CFO & Chief Business Officer | 2026-01-07 | Sale | −1,700 | $1.99 | $3,377 | 216,839 | D |
| Open-market sales · 14,905 sh · avg $1.97 · $29,436 | |||||||
Loading xslF345X05/wk-form4_1767839507.xml…